我們使用cookies為我們網站的訪問者提供最佳體驗。要了解我們如何使用cookie或如何阻止cookie,請參考我們的隱私權政策

更多資源 - 科學海報

Automated Triplexed Hepatocyte-Based Viability and CYP1A and CYP3A Induction Assays in 96- and 384-well Microplates

下載

Related Products: EL406 多功能微量盤清洗及分注儀

September 10, 2010

 

Authors: Brad Larson, Peter Banks, BioTek Instruments, Inc., Winooski, Vermont; Timothy Moeller, Celsis In Vitro Technologies, Baltimore, Maryland; James J Cali, Promega Corporation, Madison, Wisconsin

 

The ability to monitor CYP induction, inhibition, and cytotoxicity by xenobiotics using an automated, multiplexed format can decrease workloads and increase data confidence. Here we demonstrate the ability to monitor CYP1A and -3A induction, combined with a cytotoxicity measurement, from a single well using cryopreserved human hepatocytes. The assay procedure was automated in 96- and 384-well formats, including cell manipulations, compound titration and transfer, and reagent dispensing, using simple, yet robust robotic instrumentation. EC50 values were derived for multiple known inducers of CYP1A and -3A from an 11-point curve. Induction and toxicological responses in the triplex system were validated based on consistency with conventional single parameter assays. Validation and pharmacology data confi rm that multiplexed cell-based CYP assays can simplify workload, save time and effort, and generate the data needed from today’s ADME/Tox laboratory.

BioTek instruments

EL406, Synergy H4,  Precision

link